Regeneron Pharmaceuticals is focused on the development of pharmaceutical products for the treatment of serious medical conditions.



Post IPO Equity




Org chart

Leonard S. Schleifer
Founder, President & CEO
Neil Stahl
Daniel Van Plew
EVP & General Manager, Industrial Operations and Product Supply
Bill Olson
SVP, Therapeutic Proteins
Deborah Tegan
SVP, Strategic Sourcing and Procurement
George D. Yancopoulos
President & Chief Scientific Officer
Joseph J. LaRosa
SVP, General Counsel & Secretary
Kerry Reinertsen
SVP, Strategic Alliances
Marion McCourt
SVP, Commercial
Nouhad Husseini
SVP, Business Development
Robert E. Landry
SVP, Finance & CFO
Beth F. Holly
SVP & Former Chief Compliance Officer
Jenny Mcnay
SVP, CMC Regulatory Sciences and Industrial Affairs 
Smita Pillai
Chief Diversity, Equity & Inclusion Officer
Randy Soltys
SVP, Drug Safety and Pharmacometrics
Bari Kowal
SVP, Development Operations & Portfolio Planning
Chris Fenimore
SVP, Head of Accounting and Controller
Bob Mccowan
SVP, IT and Chief Information Officer
Niall O’Leary
SVP and Site Head, IOPS Raheen
Maya Bermingham
SVP, Public Policy & Government Affairs
Ron Wang
SVP, Quality Control
Johnathan M. Lancaster
SVP, Global Medical Affairs
Gonzalo Merino
SVP, Chief Intellectual Property Counsel and Associate General Counsel
Boaz Hirshberg
SVP, Clinical Sciences General Medicine
Christina Chan
SVP, Corporate Communications & Citizenship
David Snow
SVP, Global Head, Duxipent Franchise
Bola Akinlade
SVP, Clinical Development, Immunology & Inflammation
Zoran Berkovic
SVP, Financial Planning & Analysis
David Simon
SVP, IOPS Finance & Business Operations
Richard O’neal
SVP, Market Access
Gang Chen
SVP, Protein Expression Sciences
Christos Kyratsous
SVP, Research
Mark Volpe
SVP, Tax
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.